Millennium/EntreMed Show Opposite Ends Of Biotech Hype Cycle
Executive Summary
Wall Street's muted reaction to Millennium's recent announcements of progress in understanding the genetic basis of obesity illustrates the fickle nature of hype involving biotechnology research.